Cell-free DNA analysis for noninvasive examination of trisomy

Medicine & Life Sciences

• Cell-Free Nucleic Acids 100%
• Trisomy 97%
• Down Syndrome 41%
• Confidence Intervals 28%
• Nuchal Translucency Measurement 22%
• Area Under Curve 12%
• Noninvasive Prenatal Testing 12%
• Trisomy 13 Syndrome 11%
• Trisomy 18 Syndrome 10%
• Aneuploidy 8%
• Maternal Age 8%
• Genetic Testing 8%
• First Pregnancy Trimester 8%
• Multicenter Studies 6%
• Gestational Age 6%
• ROC Curve 6%
• Pregnant Women 6%
• Population 6%
• Newborn Infant 6%
• Parturition 5%
• Pregnancy 4%